Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus

Abstract

A major barrier to research on Parkinson's disease is inaccessibility of diseased tissue for study. One solution is to derive induced pluripotent stem cells from patients and differentiate them into neurons affected by disease. Triplication of SNCA, encoding α-synuclein, causes a fully penetrant, aggressive form of Parkinson's disease with dementia. α-Synuclein dysfunction is the critical pathogenic event in Parkinson's disease, multiple system atrophy and dementia with Lewy bodies. Here we produce multiple induced pluripotent stem cell lines from an SNCA triplication patient and an unaffected first-degree relative. When these cells are differentiated into midbrain dopaminergic neurons, those from the patient produce double the amount of α-synuclein protein as neurons from the unaffected relative, precisely recapitulating the cause of Parkinson's disease in these individuals. This model represents a new experimental system to identify compounds that reduce levels of α-synuclein, and to investigate the mechanistic basis of neurodegeneration caused by α-synuclein dysfunction.

Using iPSC‐derived human DA neurons from opioid‐dependent subjects to study dopamine dynamics

“…2012), Huntington's disease (HD) (HD iPSC Consortium 2012), and Parkinson's disease (PD) (Devine et al. 2011). However, to the best of our knowledge, only one pilot study reported research using human iPSC‐derived neural cells in alcohol abuse (Lieberman et al.…”

Glucocerebrosidase mutations and the pathogenesis of Parkinson disease

“…From each culture of reprogrammed fibroblasts, colonies are selected and are subjected to quality-control measures such as transgene silencing and karyotype analysis. However, these clones, colonies derived from the same human donor, still exhibit large variability (Devine et al, 2011). This can lead to considerable phenotypic variability that is unrelated to their genotype and a differing efficiency to which iPSC lines differentiate into neurons (Sánchez-Danés et al, 2012).…”

Induced Pluripotent Stem Cell Technology and Direct Conversion: New Possibilities to Study and Treat Parkinson’s Disease

“…the role of α-synuclein or LRRK2, etc. ), particularly when the iPSCs are generated from patients with a hereditary form of Parkinson's disease [29,30].…”